Clal Insurance’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,684
Closed -$145K 219
2021
Q4
$145K Buy
10,684
+3,349
+46% +$47.4K ﹤0.01% 187
2021
Q3
$108K Buy
+7,335
New +$124K ﹤0.01% 210

Other funds holding SBRA

Clal Insurance's SBRA Position: Q1 2022 in Review

Clal Insurance sold out of Sabra Healthcare REIT (SBRA) in Q1 2022, closing a stake of 10,684 shares — an estimated $145K sold.

Clal Insurance first reported a position in SBRA in Q3 2021 and held it in 2 quarters. The position peaked at $145K in Q4 2021. 326 funds tracked by Wall St. Rank hold SBRA as of Q1 2022.

  • Clal Insurance reported no remaining Sabra Healthcare REIT position as of Q1 2022 after selling out during the quarter.
  • Clal Insurance sold 10,684 Sabra Healthcare REIT shares in Q1 2022, an estimated $145K.
  • Clal Insurance first reported a position in Sabra Healthcare REIT in Q3 2021 and held it in 2 quarters.
  • Clal Insurance's Sabra Healthcare REIT position peaked at $145K in Q4 2021.
  • 326 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2022.

Based on Clal Insurance's 13F filing for Q1 2022, filed 12 May 2022.